- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Spain withdraws cervical cancer shot
Author(s):
Madrid ? Spanish authorities withdrew 76,000 doses of Gardasil (human papillomavirus quadrivalent vaccine, recombinant, Merck) from the market in February after two teenagers who received the vaccine were hospitalized, according to the news agency Agence France-Presse.
Madrid
- Spanish authorities withdrew 76,000 doses of Gardasil (human papillomavirus quadrivalent vaccine, recombinant, Merck) from the market in February after two teenagers who received the vaccine were hospitalized, according to the news agency Agence France-Presse.
The two girls were vaccinated as part of a government program targeting adolescents, and were later hospitalized in stable condition in intensive care, according to a health official.
Spanish health authorities said in a statement that the batch of Gardasil was distributed countrywide, with some earmarked for regional vaccination programs and the rest sold at pharmacies, according to the AFP.
